A. Garcia-sastre and C. A. Biron, Type 1 Interferons and the Virus-Host Relationship: A Lesson in Detente, Science, vol.312, issue.5775, pp.879-882, 2006.
DOI : 10.1126/science.1125676

D. B. Stetson and R. Medzhitov, Antiviral defense: interferons and beyond: Figure 1., The Journal of Experimental Medicine, vol.152, issue.8, pp.1837-1841, 2006.
DOI : 10.1073/pnas.0601523103

E. S. Coro, W. L. Chang, and N. Baumgarth, Type I IFN Receptor Signals Directly Stimulate Local B Cells Early following Influenza Virus Infection, The Journal of Immunology, vol.176, issue.7, pp.4343-4351, 2006.
DOI : 10.4049/jimmunol.176.7.4343

J. M. Curtsinger, J. O. Valenzuela, P. Agarwal, D. Lins, and M. F. Mescher, Cutting Edge: Type I IFNs Provide a Third Signal to CD8 T Cells to Stimulate Clonal Expansion and Differentiation, The Journal of Immunology, vol.174, issue.8, pp.4465-4469, 2005.
DOI : 10.4049/jimmunol.174.8.4465

G. Jego, A. K. Palucka, J. P. Blanck, C. Chalouni, V. Pascual et al., Plasmacytoid Dendritic Cells Induce Plasma Cell Differentiation through Type I Interferon and Interleukin 6, Immunity, vol.19, issue.2, pp.225-234, 2003.
DOI : 10.1016/S1074-7613(03)00208-5

G. A. Kolumam, S. Thomas, L. J. Thompson, J. Sprent, and K. Murali-krishna, Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection, The Journal of Experimental Medicine, vol.4, issue.5, pp.637-650, 2005.
DOI : 10.1038/37648

M. B. Litinskiy, B. Nardelli, D. M. Hilbert, B. He, A. Schaffer et al., DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL, Nature Immunology, vol.3, issue.9, pp.822-829, 2002.
DOI : 10.1038/ni829

X. Zhang, S. Sun, I. Hwang, D. F. Tough, and J. Sprent, Potent and Selective Stimulation of Memory-Phenotype CD8+ T Cells In Vivo by IL-15, Immunity, vol.8, issue.5, pp.591-599, 1998.
DOI : 10.1016/S1074-7613(00)80564-6

A. Krug, R. Veeraswamy, A. Pekosz, O. Kanagawa, E. R. Unanue et al., Interferon-producing Cells Fail to Induce Proliferation of Naive T Cells but Can Promote Expansion and T Helper 1 Differentiation of Antigen-experienced Unpolarized T Cells, The Journal of Experimental Medicine, vol.66, issue.7, pp.899-906, 2003.
DOI : 10.1078/0171-2985-00092

K. B. Nguyen, W. T. Watford, R. Salomon, S. R. Hofmann, G. C. Pien et al., Critical Role for STAT4 Activation by Type 1 Interferons in the Interferon-gamma Response to Viral Infection, Science, vol.297, issue.5589, pp.2063-2066, 2002.
DOI : 10.1126/science.1074900

L. Bon, A. Schiavoni, G. Agostino, G. Gresser, I. Belardelli et al., Type I Interferons Potently Enhance Humoral Immunity and Can Promote Isotype Switching by Stimulating Dendritic Cells In Vivo, Immunity, vol.14, issue.4, pp.461-470, 2001.
DOI : 10.1016/S1074-7613(01)00126-1

L. Bon, A. Etchart, N. Rossmann, C. Ashton, M. Hou et al., Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon, Nature Immunology, vol.4, issue.10, pp.1009-1015, 2003.
DOI : 10.1038/ni978

M. Montoya, G. Schiavoni, F. Mattei, I. Gresser, F. Belardelli et al., Type I interferons produced by dendritic cells promote their phenotypic and functional activation, Blood, vol.99, issue.9, pp.3263-3271, 2002.
DOI : 10.1182/blood.V99.9.3263

E. C. Shin, U. Seifert, K. Takanobu, C. M. Rice, S. M. Feinstone et al., Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection, Journal of Clinical Investigation, vol.116, issue.11, pp.3006-3014, 2006.
DOI : 10.1172/JCI29832DS1

P. Lampertico, M. Rumi, R. Romeo, A. Craxi, R. Soffredini et al., A multicenter randomized controlled trial of recombinant interferon-??2b in patients with acute transfusion-associated hepatitis C, Hepatology, vol.16, issue.1, pp.19-22, 1994.
DOI : 10.1002/hep.1840190105

L. Bon, A. Thompson, C. Kamphuis, E. Durand, V. Rossmann et al., Cutting Edge: Enhancement of Antibody Responses Through Direct Stimulation of B and T Cells by Type I IFN, The Journal of Immunology, vol.176, issue.4, pp.2074-2078, 2006.
DOI : 10.4049/jimmunol.176.4.2074

A. Mathian, A. Weinberg, M. Gallegos, J. Banchereau, and S. Koutouzov, IFN-?? Induces Early Lethal Lupus in Preautoimmune (New Zealand Black x New Zealand White)F1 but Not in BALB/c Mice, The Journal of Immunology, vol.174, issue.5, pp.2499-2506, 2005.
DOI : 10.4049/jimmunol.174.5.2499

E. Proietti, L. Bracci, S. Puzelli, D. Pucchio, T. Sestili et al., Type I IFN as a Natural Adjuvant for a Protective Immune Response: Lessons from the Influenza Vaccine Model, The Journal of Immunology, vol.169, issue.1, pp.375-383, 2002.
DOI : 10.4049/jimmunol.169.1.375

M. L. Santiago-raber, R. Baccala, K. M. Haraldsson, D. Choubey, T. A. Stewart et al., Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice, The Journal of Experimental Medicine, vol.154, issue.6, pp.777-788, 2003.
DOI : 10.1038/ni0901-785

H. Gogas, J. Ioannovich, U. Dafni, C. Stavropoulou-giokas, K. Frangia et al., Prognostic Significance of Autoimmunity during Treatment of Melanoma with Interferon, New England Journal of Medicine, vol.354, issue.7, pp.709-718, 2006.
DOI : 10.1056/NEJMoa053007

A. N. Theofilopoulos, R. Baccala, B. Beutler, and D. H. Kono, TYPE I INTERFERONS (??/??) IN IMMUNITY AND AUTOIMMUNITY, Annual Review of Immunology, vol.23, issue.1, pp.307-336, 2005.
DOI : 10.1146/annurev.immunol.23.021704.115843

D. Emilie, M. Burgard, C. Lascoux-combe, M. Laughlin, R. Krzysiek et al., Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFN : results from the Primoferon A (ANRS 086) Study, Primoferon A Study Group. AIDS, vol.15, pp.1435-1437, 2001.

L. Adalid-peralta, L. Grangeot-keros, A. Rudent, N. Ngo-giang-huong, R. Krzyiek et al., Impact of highly active antiretroviral therapy on the maturation of anti-HIV-1 antibodies during primary HIV-1 infection, HIV Medicine, vol.103, issue.8, pp.514-519, 2006.
DOI : 10.1046/j.1365-2249.2000.01144.x

J. M. Fondere, M. F. Huguet, H. Yssel, V. Baillat, J. Reynes et al., Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy, AIDS, vol.17, issue.16, pp.2323-2330, 2003.
DOI : 10.1097/00002030-200311070-00006

I. Kamga, S. Kahi, L. Develioglu, M. Lichtner, C. Maranon et al., Type I Interferon Production Is Profoundly and Transiently Impaired in Primary HIV???1 Infection, The Journal of Infectious Diseases, vol.192, issue.2, pp.303-310, 2005.
DOI : 10.1086/430931

C. Servet, L. Zitvogel, and A. Hosmalin, Dendritic Cells in Innate Immune Responses Against HIV, Current Molecular Medicine, vol.2, issue.8, pp.739-756, 2002.
DOI : 10.2174/1566524023361907

. Adalid-peralta, Stimulation of anti-HIV antibody response by
URL : https://hal.archives-ouvertes.fr/inserm-00263595

K. Titanji, F. Chiodi, R. Bellocco, D. Schepis, L. Osorio et al., Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions, AIDS, vol.19, issue.17, pp.1947-1955, 2005.
DOI : 10.1097/01.aids.0000191231.54170.89

C. Lapenta, S. M. Santini, M. Logozzi, M. Spada, M. Andreotti et al., Potent Immune Response against HIV-1 and Protection from Virus Challenge in hu-PBL-SCID Mice Immunized with Inactivated Virus-pulsed Dendritic Cells Generated in the Presence of IFN-??, The Journal of Experimental Medicine, vol.160, issue.2, pp.361-367, 2003.
DOI : 10.1038/85493

S. M. Santini, C. Lapenta, M. Logozzi, S. Parlato, M. Spada et al., Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice, The Journal of Experimental Medicine, vol.162, issue.10, pp.1777-1788, 2000.
DOI : 10.1038/32183

O. Connor, B. P. Raman, V. S. Erickson, L. D. Cook, W. J. Weaver et al., BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells, The Journal of Experimental Medicine, vol.157, issue.1, pp.91-97, 2004.
DOI : 10.1038/nsb769

D. T. Avery, S. L. Kalled, J. I. Ellyard, C. Ambrose, S. A. Bixter et al., BAFF selectively enhances the survival of plasmablasts generated from human memory B cells, Journal of Clinical Investigation, vol.112, issue.2, pp.286-297, 2003.
DOI : 10.1172/JCI18025

G. Trinchieri, Interleukin-12 and the regulation of innate resistance and adaptive immunity, Nature Reviews Immunology, vol.3, issue.2, pp.133-146, 2003.
DOI : 10.1038/nri1001

T. W. Baba, V. Liska, R. Hofmann-lehmann, J. Vlasak, W. Xu et al., Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection, Nat. Med, vol.6, pp.200-206, 2000.

S. D. Frost, T. Wrin, D. M. Smith, S. L. Kosakovsky-pond, Y. Liu et al., Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection, Proc. Natl. Acad. Sci. USA, pp.18514-18519, 2005.
DOI : 10.1073/pnas.0504658102

M. C. Gauduin, P. W. Parren, R. Weir, C. F. Barbas, D. R. Burton et al., Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1, Nature Medicine, vol.10, issue.12, pp.1389-1393, 1997.
DOI : 10.1038/nm1297-1389

P. D. Kwong, M. L. Doyle, D. J. Casper, C. Cicala, S. A. Leavitt et al., HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites, Nature, vol.85, issue.6916, pp.678-682, 2002.
DOI : 10.1128/JVI.74.4.1961-1972.2000

J. R. Mascola, G. Stiegler, T. C. Vancott, H. Katinger, C. B. Carpenter et al., Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies, AIDS, vol.15, pp.207-210, 2000.
DOI : 10.1097/00002030-200102001-00018

D. D. Richman, T. Wrin, S. J. Little, and C. J. Petropoulos, Rapid evolution of the neutralizing antibody response to HIV type 1 infection, Proc. Natl. Acad. Sci. USA, pp.4144-4149, 2003.
DOI : 10.1073/pnas.0630530100

R. Shibata, T. Igarashi, N. Haigwood, A. Buckler-white, R. Ogert et al., Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys, Nature Medicine, vol.5, issue.2, pp.204-210, 1999.
DOI : 10.1038/5568

A. Trkola, H. Kuster, P. Rusert, B. Joos, M. Fischer et al., Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies, Nature Medicine, vol.14, issue.6, pp.615-622, 2005.
DOI : 10.1016/j.virol.2004.05.022

R. S. Veazey, R. J. Shattock, M. Pope, J. C. Kirijan, J. Jones et al., Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120, Nature Medicine, vol.9, issue.3, pp.343-346, 2003.
DOI : 10.1038/nm833

A. Lafeuillade, C. Poggi, C. Tamalet, N. Profizi, C. Tourres et al., Effects of a Combination of Zidovudine, Didanosine, and Lamivudine on Primary Human Immunodeficiency Virus Type 1 Infection, The Journal of Infectious Diseases, vol.175, issue.5, pp.1051-1055, 1997.
DOI : 10.1086/516442

M. Markowitz, M. Vesanen, K. Tenner-racz, Y. Cao, J. M. Binley et al., The Effect of Commencing Combination Antiretroviral Therapy Soon after Human Immunodeficiency Virus Type 1 Infection on Viral Replication and Antiviral Immune Responses, The Journal of Infectious Diseases, vol.179, issue.3, pp.527-537, 1999.
DOI : 10.1086/314628

A. Radbruch, G. Muehlinghaus, E. O. Luger, A. Inamine, K. G. Smith et al., Competence and competition: the challenge of becoming a long-lived plasma cell, Nature Reviews Immunology, vol.106, issue.10, pp.741-750, 2006.
DOI : 10.1038/nri1886

X. Wei, J. M. Decker, S. Wang, H. Hui, J. C. Kappes et al., Antibody neutralization and escape by HIV-1, Nature, vol.422, issue.6929, pp.307-312, 2003.
DOI : 10.1038/nature01470

M. M. Aasa-chapman, S. Holuigue, K. Aubin, M. Wong, N. A. Jones et al., Detection of Antibody-Dependent Complement-Mediated Inactivation of both Autologous and Heterologous Virus in Primary Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, vol.79, issue.5, pp.2823-2830, 2005.
DOI : 10.1128/JVI.79.5.2823-2830.2005

E. Connick, D. G. Marr, X. Q. Zhang, S. J. Clark, M. S. Saag et al., HIV-Specific Cellular and Humoral Immune Responses in Primary HIV Infection, AIDS Research and Human Retroviruses, vol.12, issue.12, pp.1129-1140, 1996.
DOI : 10.1089/aid.1996.12.1129

D. N. Forthal, G. Landucci, and E. S. Daar, Antibody from Patients with Acute Human Immunodeficiency Virus (HIV) Infection Inhibits Primary Strains of HIV Type 1 in the Presence of Natural-Killer Effector Cells, Journal of Virology, vol.75, issue.15, pp.6953-6961, 2001.
DOI : 10.1128/JVI.75.15.6953-6961.2001

M. Huber, M. Fischer, B. Misselwitz, A. Manrique, H. Kuster et al., Complement Lysis Activity in Autologous Plasma Is Associated with Lower Viral Loads during the Acute Phase of HIV-1 Infection, PLoS Medicine, vol.99, issue.11, p.441, 2006.
DOI : 10.1371/journal.pmed.0030441.st001